Phase II Trial O6-benzylguanine(BG) and Temozolomide(TMZ) Therapy of Glioblastoma Multiforme (GBM) With Infusion of Autologous P140K MGMT+Hematopoietic Progenitors to Protect Hematopoiesis
This study tests a new way to treat an aggressive type of brain tumor called glioblastoma using chemotherapy alongside a special gene therapy. The goal is to protect your bone marrow so doctors can use higher, more effective doses of cancer-fighting medicine.
You may be able to join if you are 18 or older, had recent surgery to remove a specific type of upper brain tumor within the last 35 days, and are generally well enough to handle daily activities. Certain health conditions, pregnancy, or major heart and lung issues will mean you cannot participate.
You will receive treatments including chemotherapy medications, radiation therapy, and a special bone marrow protection therapy to help your body handle the strong medicines. Doctors will monitor you closely with scans and checkups throughout the process.
This study is currently recruiting participants and takes place in Cleveland, Ohio, United States.
- 1Tests stronger chemotherapy doses while protecting your bone marrow
- 2For adults with a specific type of recently removed brain tumor
- 3Currently recruiting patients in Cleveland, Ohio
Related video
Related links
Outside pages about this study, checked by our team
This summary was generated using AI and may not capture all details. Always consult with a healthcare professional for medical advice.